EUVIMEDEUVIMED entdecken
Crossref

Salivary thioredoxin-1 as a non-invasive redox biomarker in oral diseases

Sivan Sathish, Ankita Jain, Haritma Nigam, Vikas Singh, Upender Malik

World Journal of Clinical Cases · 06.08.2026 · 14 (22)

DOI: 10.12998/wjcc.123160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Clinical Cases, online erschienen am 06.08.2026. Verfasst von Sivan Sathish und 4 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thioredoxin-1 (Trx-1) is a key redox-regulating protein involved in antioxidant defense, inflammation, immune responses, and cell survival. Dysregulation of redox balance is increasingly being recognized as a central mechanism in the pathogenesis of a wide spectrum of oral diseases, ranging from inflammatory conditions to oral potentially malignant disorders and oral squamous cell carcinoma. Saliva, owing to its non-invasive, accessible, and disease-reflective nature, has emerged as a promising diagnostic medium for redox and inflammatory biomarkers. Limited but emerging evidence suggests that salivary Trx-1 levels may be altered in oral diseases associated with oxidative stress and chronic inflammation, reflecting underlying molecular and cellular changes within the oral microenvironment. From a clinical perspective, assessment of salivary Trx-1 may assist in early disease detection, chairside risk stratification, and longitudinal monitoring of disease activity and treatment response. Elevated salivary Trx-1 expression has been associated with disease presence, severity, and malignant transformation risk, highlighting its potential diagnostic and prognostic utility. Despite these advantages, variability in detection methods, population heterogeneity, and limited longitudinal data remain challenges to clinical translation. Overall, salivary Trx-1 represents a promising non-invasive redox biomarker with significant potential for improving early detection, risk assessment, and personalized management of oral diseases.

Zitieren

APA

Sathish, S., Jain, A., Nigam, H., Singh, V., & Malik, U. (2026). Salivary thioredoxin-1 as a non-invasive redox biomarker in oral diseases. World Journal of Clinical Cases, 14(22). https://doi.org/10.12998/wjcc.123160

Vancouver

Sathish S, Jain A, Nigam H, Singh V, Malik U. Salivary thioredoxin-1 as a non-invasive redox biomarker in oral diseases. World Journal of Clinical Cases. 2026;14(22). doi:10.12998/wjcc.123160

BibTeX
@article{Sathish2026,
  author = {Sathish, Sivan and Jain, Ankita and Nigam, Haritma and Singh, Vikas and Malik, Upender},
  title = {Salivary thioredoxin-1 as a non-invasive redox biomarker in oral diseases},
  journal = {World Journal of Clinical Cases},
  year = {2026},
  volume = {14},
  number = {22},
  doi = {10.12998/wjcc.123160}
}
Kostenlos starten →